Cyclosporine API - Global and China Top Players Market Share and Ranking 2023
- Report Code : AMP2757235
- Published On: Oct, 2024
- Category : Chemicals & Materials
- Pages : 152
-
According to Ample Market Research, the global market for Cyclosporine API should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Cyclosporine API market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Cyclosporine API market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Capsule grew percent to account for percent of the total market sales, and Tablet grew percent.
This report studies and analyses global Cyclosporine API status and future trends, helps the client to determine the Cyclosporine API market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Cyclosporine API, and provides market size (in Tons & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Cyclosporine API market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (Tons)
(2) Global Cyclosporine API sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(3) China Cyclosporine API sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(4) Global Cyclosporine API key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Cyclosporine API key producing regions, capacity, production, and year over year growth
(6) Cyclosporine API industry chains, upstream, midstream and downstream
Market segment by players, this report covers
CURIA ITALY SRL
TEVA PHARMACEUTICAL INDUSTRIES LTD
NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD
CONCORD BIOTECH LTD
APOTEX PHARMACHEM INC
CHEMWERTH INC
ABBVIE INC
CKD BIO CORP
ZHEJIANG RUIBANG LABORATORIES
HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD
Guangdong Tesunde Pharmaceutical
Fujian Kerui Pharmaceutical
North China Pharmaceutical Huasheng
Sinopharm Sichuan Kang Pharmaceutical
Jiangsu Joyoung Biopharmaceuticals
Market segment by Type, covers
Purity≥99%
Purity<99%
Market segment by Application, can be divided into
Capsule
Tablet
Injection
Eye Drops
Eye Gel
Eye Cream
Oral Solution
Granules
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Cyclosporine API product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Cyclosporine API market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Cyclosporine API market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Cyclosporine API, percent & CAGR, 2018-2029
Chapter 5: Cyclosporine API industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
-
With tables and figures helping analyze worldwide Cyclosporine API Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Cyclosporine API Definition
1.2 Global Cyclosporine API Market Size and Forecast
1.2.1 By Consumption Value, Global Cyclosporine API Market Size，2018-2029
1.2.2 By Sales Quantity, Global Cyclosporine API Market Size，2018-2029
1.2.3 Global Cyclosporine API Average Selling Price (ASP)，2018-20291.3 China Cyclosporine API Market Size and Forecast
1.3.1 By Consumption Value, China Cyclosporine API Market Size，2018-2029
1.3.2 By Sales Quantity, China Cyclosporine API Market Size，2018-2029
1.3.3 China Cyclosporine API Average Selling Price (ASP)， 2018-20291.4 Share of China Cyclosporine API Market with Respect to the Global Market
1.4.1 By Consumption Value, China Cyclosporine API Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Cyclosporine API Market Share in Global, 2018-2029
1.4.3 Cyclosporine API Market Size: China VS Global, 2018-20291.5 Cyclosporine API Market Dynamics
1.5.1 Cyclosporine API Market Drivers
1.5.2 Cyclosporine API Market Restraints
1.5.3 Cyclosporine API Industry Trends
1.5.4 Cyclosporine API Industry Policy
2 Global Leading Manufacturers and Market Share2.1 By Revenue of Cyclosporine API, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Cyclosporine API, Global Market Share by Company, 2018-2023
2.3 Cyclosporine API Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Cyclosporine API Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Cyclosporine API Concentration Ratio
2.6 Global Cyclosporine API Mergers & Acquisitions, Expansion Plans
2.7 Global Cyclosporine API Manufacturers Product Type
2.8 Head Office and Cyclosporine API Production Site of Key Manufacturer
2.9 Cyclosporine API Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share3.1 By Revenue of Cyclosporine API, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Cyclosporine API, China Market Share by Company, 2018-2023
3.3 China Cyclosporine API Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions4.1 Global Cyclosporine API Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Cyclosporine API Capacity by Region
4.3 Global Cyclosporine API Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Cyclosporine API Production by Region, 2018-2029
4.5 Global Cyclosporine API Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis5.1 Cyclosporine API Industry Chain
5.2 Cyclosporine API Upstream Analysis
5.2.1 Cyclosporine API Core Raw Materials
5.2.2 Main Manufacturers of Cyclosporine API Core Raw Materials5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Cyclosporine API Production Mode
5.6 Cyclosporine API Procurement Model
5.7 Cyclosporine API Industry Sales Model and Sales Channels
5.7.1 Cyclosporine API Sales Model
5.7.2 Cyclosporine API Typical Distributors
6 Sights by Type6.1 Cyclosporine API Classification
6.1.1 Purity≥99%
6.1.2 Purity<99%6.2 By Type, Global Cyclosporine API Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Cyclosporine API Consumption Value, 2018-2029
6.4 By Type, Global Cyclosporine API Sales Quantity, 2018-2029
6.5 By Type, Global Cyclosporine API Average Selling Price (ASP), 2018-2029
7 Sights by Application7.1 Cyclosporine API Segment by Application
7.1.1 Capsule
7.1.2 Tablet
7.1.3 Injection
7.1.4 Eye Drops
7.1.5 Eye Gel
7.1.6 Eye Cream
7.1.7 Oral Solution
7.1.8 Granules7.2 By Application, Global Cyclosporine API Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Cyclosporine API Consumption Value, 2018-2029
7.4 By Application, Global Cyclosporine API Sales Quantity, 2018-2029
7.5 By Application, Global Cyclosporine API Price, 2018-2029
8 Sales Sights by Region8.1 By Region, Global Cyclosporine API Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Cyclosporine API Consumption Value, 2018-2029
8.3 By Region, Global Cyclosporine API Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Cyclosporine API & Forecasts, 2018-2029
8.4.2 By Country, North America Cyclosporine API Market Size Market Share8.5 Europe
8.5.1 Europe Cyclosporine API Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Cyclosporine API Market Size Market Share8.6 Asia Pacific
8.6.1 Asia Pacific Cyclosporine API Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Cyclosporine API Market Size Market Share
8.7 South America
8.7.1 South America Cyclosporine API Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Cyclosporine API Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level9.1 By Country, Global Cyclosporine API Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Cyclosporine API Consumption Value, 2018-2029
9.3 By Country, Global Cyclosporine API Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Cyclosporine API Market Size, 2018-2029
9.4.2 By Type, U.S. Cyclosporine API Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Cyclosporine API Sales Quantity Market Share, 2022 VS 20299.5 Europe
9.5.1 Europe Cyclosporine API Market Size, 2018-2029
9.5.2 By Type, Europe Cyclosporine API Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Cyclosporine API Sales Quantity Market Share, 2022 VS 20299.6 China
9.6.1 China Cyclosporine API Market Size, 2018-2029
9.6.2 By Type, China Cyclosporine API Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Cyclosporine API Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Cyclosporine API Market Size, 2018-2029
9.7.2 By Type, Japan Cyclosporine API Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Cyclosporine API Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Cyclosporine API Market Size, 2018-2029
9.8.2 By Type, South Korea Cyclosporine API Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Cyclosporine API Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Cyclosporine API Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Cyclosporine API Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Cyclosporine API Sales Quantity Market Share, 2022 VS 20299.10 India
9.10.1 India Cyclosporine API Market Size, 2018-2029
9.10.2 By Type, India Cyclosporine API Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Cyclosporine API Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Cyclosporine API Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Cyclosporine API Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Cyclosporine API Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile10.1 CURIA ITALY SRL
10.1.1 CURIA ITALY SRL Company Information, Head Office, Market Area, and Industry Position
10.1.2 CURIA ITALY SRL Cyclosporine API Models, Specifications, and Application
10.1.3 CURIA ITALY SRL Cyclosporine API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 CURIA ITALY SRL Company Profile and Main Business
10.1.5 CURIA ITALY SRL Recent Developments10.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
10.2.1 TEVA PHARMACEUTICAL INDUSTRIES LTD Company Information, Head Office, Market Area, and Industry Position
10.2.2 TEVA PHARMACEUTICAL INDUSTRIES LTD Cyclosporine API Models, Specifications, and Application
10.2.3 TEVA PHARMACEUTICAL INDUSTRIES LTD Cyclosporine API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 TEVA PHARMACEUTICAL INDUSTRIES LTD Company Profile and Main Business
10.2.5 TEVA PHARMACEUTICAL INDUSTRIES LTD Recent Developments10.3 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD
10.3.1 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Company Information, Head Office, Market Area, and Industry Position
10.3.2 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Cyclosporine API Models, Specifications, and Application
10.3.3 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Cyclosporine API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Company Profile and Main Business
10.3.5 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Recent Developments10.4 CONCORD BIOTECH LTD
10.4.1 CONCORD BIOTECH LTD Company Information, Head Office, Market Area, and Industry Position
10.4.2 CONCORD BIOTECH LTD Cyclosporine API Models, Specifications, and Application
10.4.3 CONCORD BIOTECH LTD Cyclosporine API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 CONCORD BIOTECH LTD Company Profile and Main Business
10.4.5 CONCORD BIOTECH LTD Recent Developments10.5 APOTEX PHARMACHEM INC
10.5.1 APOTEX PHARMACHEM INC Company Information, Head Office, Market Area, and Industry Position
10.5.2 APOTEX PHARMACHEM INC Cyclosporine API Models, Specifications, and Application
10.5.3 APOTEX PHARMACHEM INC Cyclosporine API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 APOTEX PHARMACHEM INC Company Profile and Main Business
10.5.5 APOTEX PHARMACHEM INC Recent Developments10.6 CHEMWERTH INC
10.6.1 CHEMWERTH INC Company Information, Head Office, Market Area, and Industry Position
10.6.2 CHEMWERTH INC Cyclosporine API Models, Specifications, and Application
10.6.3 CHEMWERTH INC Cyclosporine API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 CHEMWERTH INC Company Profile and Main Business
10.6.5 CHEMWERTH INC Recent Developments
10.7 ABBVIE INC
10.7.1 ABBVIE INC Company Information, Head Office, Market Area, and Industry Position
10.7.2 ABBVIE INC Cyclosporine API Models, Specifications, and Application
10.7.3 ABBVIE INC Cyclosporine API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 ABBVIE INC Company Profile and Main Business
10.7.5 ABBVIE INC Recent Developments
10.8 CKD BIO CORP
10.8.1 CKD BIO CORP Company Information, Head Office, Market Area, and Industry Position
10.8.2 CKD BIO CORP Cyclosporine API Models, Specifications, and Application
10.8.3 CKD BIO CORP Cyclosporine API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 CKD BIO CORP Company Profile and Main Business
10.8.5 CKD BIO CORP Recent Developments
10.9 ZHEJIANG RUIBANG LABORATORIES
10.9.1 ZHEJIANG RUIBANG LABORATORIES Company Information, Head Office, Market Area, and Industry Position
10.9.2 ZHEJIANG RUIBANG LABORATORIES Cyclosporine API Models, Specifications, and Application
10.9.3 ZHEJIANG RUIBANG LABORATORIES Cyclosporine API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 ZHEJIANG RUIBANG LABORATORIES Company Profile and Main Business
10.9.5 ZHEJIANG RUIBANG LABORATORIES Recent Developments10.10 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD
10.10.1 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Company Information, Head Office, Market Area, and Industry Position
10.10.2 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Cyclosporine API Models, Specifications, and Application
10.10.3 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Cyclosporine API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Company Profile and Main Business
10.10.5 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Recent Developments
10.11 Guangdong Tesunde Pharmaceutical
10.11.1 Guangdong Tesunde Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.11.2 Guangdong Tesunde Pharmaceutical Cyclosporine API Models, Specifications, and Application
10.11.3 Guangdong Tesunde Pharmaceutical Cyclosporine API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Guangdong Tesunde Pharmaceutical Company Profile and Main Business
10.11.5 Guangdong Tesunde Pharmaceutical Recent Developments
10.12 Fujian Kerui Pharmaceutical
10.12.1 Fujian Kerui Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.12.2 Fujian Kerui Pharmaceutical Cyclosporine API Models, Specifications, and Application
10.12.3 Fujian Kerui Pharmaceutical Cyclosporine API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Fujian Kerui Pharmaceutical Company Profile and Main Business
10.12.5 Fujian Kerui Pharmaceutical Recent Developments
10.13 North China Pharmaceutical Huasheng
10.13.1 North China Pharmaceutical Huasheng Company Information, Head Office, Market Area, and Industry Position
10.13.2 North China Pharmaceutical Huasheng Cyclosporine API Models, Specifications, and Application
10.13.3 North China Pharmaceutical Huasheng Cyclosporine API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 North China Pharmaceutical Huasheng Company Profile and Main Business
10.13.5 North China Pharmaceutical Huasheng Recent Developments
10.14 Sinopharm Sichuan Kang Pharmaceutical
10.14.1 Sinopharm Sichuan Kang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.14.2 Sinopharm Sichuan Kang Pharmaceutical Cyclosporine API Models, Specifications, and Application
10.14.3 Sinopharm Sichuan Kang Pharmaceutical Cyclosporine API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Sinopharm Sichuan Kang Pharmaceutical Company Profile and Main Business
10.14.5 Sinopharm Sichuan Kang Pharmaceutical Recent Developments
10.15 Jiangsu Joyoung Biopharmaceuticals
10.15.1 Jiangsu Joyoung Biopharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.15.2 Jiangsu Joyoung Biopharmaceuticals Cyclosporine API Models, Specifications, and Application
10.15.3 Jiangsu Joyoung Biopharmaceuticals Cyclosporine API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Jiangsu Joyoung Biopharmaceuticals Company Profile and Main Business
10.15.5 Jiangsu Joyoung Biopharmaceuticals Recent Developments
11 Conclusion
12 Appendix12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources12.3 Market Estimation Model
12.4 Disclaimer
-
The Cyclosporine API Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Cyclosporine API Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Cyclosporine API Global and China Top Players has a wide range of applications, including
The Cyclosporine API Global and China Top Players Market study evaluates the year spans as follows: Historical year: 2018 to 2023; Base year: 2023; Forecast period**: 2024 to 2029 [** unless otherwise stated]
As the shift to value addition continues, companies in the Cyclosporine API Global and China Top Players Market face the dual challenge of improving interoperability to optimize performance and experience.
The majority of data for the Cyclosporine API Global and China Top Players Industry is gathered through primary sources, which include interviews and surveys with industry experts from the core and related industries involved in the supply chain. Secondary sources, such as SEC filings, annual reports, whitepapers, and press releases, are also used.
